AAAAAA

   
Results: 1-23 |
Results: 23
SABIN,ALBERT,BRUCE 1906-1993
Authors: CHANOCK RM
Citation: Rm. Chanock, SABIN,ALBERT,BRUCE 1906-1993, Proceedings of the Association of American Physicians, 110(1), 1998, pp. 84-86
SABIN,ALBERT,BRUCE 1906-1993
Authors: CHANOCK RM
Citation: Rm. Chanock, SABIN,ALBERT,BRUCE 1906-1993, Proceedings of the Association of American Physicians, 110(1), 1998, pp. 84-86
ISOLATION OF A 2ND RECOMBINANT HUMAN RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL-ANTIBODY FRAGMENT (FAB RSVF2-5) THAT EXHIBITS THERAPEUTIC EFFICACY IN-VIVO
Authors: CROWE JE GILMOUR PS MURPHY BR CHANOCK RM DUAN LX POMERANTZ RJ PILKINGTON GR
Citation: Je. Crowe et al., ISOLATION OF A 2ND RECOMBINANT HUMAN RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL-ANTIBODY FRAGMENT (FAB RSVF2-5) THAT EXHIBITS THERAPEUTIC EFFICACY IN-VIVO, The Journal of infectious diseases, 177(4), 1998, pp. 1073-1076
CONSTRUCTION OF 4 DOUBLE GENE SUBSTITUTION HUMAN X BOVINE ROTAVIRUS REASSORTANT VACCINE CANDIDATES - EACH BEARS 2 OUTER CAPSID HUMAN ROTAVIRUS GENES, ONE ENCODING P-SEROTYPE 1A AND THE OTHER ENCODING G-SEROTYPE-1, G-SEROTYPE-2, G-SEROTYPE-3, OR G-SEROTYPE-4 SPECIFICITY
Authors: HOSHINO Y JONES RW CHANOCK RM KAPIKIAN AZ
Citation: Y. Hoshino et al., CONSTRUCTION OF 4 DOUBLE GENE SUBSTITUTION HUMAN X BOVINE ROTAVIRUS REASSORTANT VACCINE CANDIDATES - EACH BEARS 2 OUTER CAPSID HUMAN ROTAVIRUS GENES, ONE ENCODING P-SEROTYPE 1A AND THE OTHER ENCODING G-SEROTYPE-1, G-SEROTYPE-2, G-SEROTYPE-3, OR G-SEROTYPE-4 SPECIFICITY, Journal of medical virology, 51(4), 1997, pp. 319-325
REMINISCENCES OF SABIN,ALBERT AND HIS SUCCESSFUL STRATEGY FOR THE DEVELOPMENT OF THE LIVE ORAL POLIOVIRUS VACCINE
Authors: CHANOCK RM
Citation: Rm. Chanock, REMINISCENCES OF SABIN,ALBERT AND HIS SUCCESSFUL STRATEGY FOR THE DEVELOPMENT OF THE LIVE ORAL POLIOVIRUS VACCINE, Proceedings of the Association of American Physicians, 108(2), 1996, pp. 117-126
JENNERIAN AND MODIFIED JENNERIAN APPROACH TO VACCINATION AGAINST ROTAVIRUS DIARRHEA USING A QUADRIVALENT RHESUS ROTAVIRUS (RRV) AND HUMAN-RRV REASSORTANT VACCINE
Authors: KAPIKIAN AZ HOSHINO Y CHANOCK RM PEREZSCHAEL I
Citation: Az. Kapikian et al., JENNERIAN AND MODIFIED JENNERIAN APPROACH TO VACCINATION AGAINST ROTAVIRUS DIARRHEA USING A QUADRIVALENT RHESUS ROTAVIRUS (RRV) AND HUMAN-RRV REASSORTANT VACCINE, Archives of virology, 1996, pp. 163-175
DENGUE TYPE-4 VIRUS MUTANTS CONTAINING DELETIONS IN THE 3'-NONCODING REGION OF THE RNA GENOME - ANALYSIS OF GROWTH RESTRICTION IN CELL-CULTURE AND ALTERED VIREMIA PATTERN AND IMMUNOGENICITY IN RHESUS-MONKEYS
Authors: MEN RH BRAY M CLARK D CHANOCK RM LAI CJ
Citation: Rh. Men et al., DENGUE TYPE-4 VIRUS MUTANTS CONTAINING DELETIONS IN THE 3'-NONCODING REGION OF THE RNA GENOME - ANALYSIS OF GROWTH RESTRICTION IN CELL-CULTURE AND ALTERED VIREMIA PATTERN AND IMMUNOGENICITY IN RHESUS-MONKEYS, Journal of virology, 70(6), 1996, pp. 3930-3937
EFFICACY OF A QUADRIVALENT RHESUS ROTAVIRUS-BASED HUMAN ROTAVIRUS VACCINE AIMED AT PREVENTING SEVERE ROTAVIRUS DIARRHEA IN INFANTS AND YOUNG-CHILDREN
Authors: KAPIKIAN AZ HOSHINO Y CHANOCK RM PEREZSCHAEL I
Citation: Az. Kapikian et al., EFFICACY OF A QUADRIVALENT RHESUS ROTAVIRUS-BASED HUMAN ROTAVIRUS VACCINE AIMED AT PREVENTING SEVERE ROTAVIRUS DIARRHEA IN INFANTS AND YOUNG-CHILDREN, The Journal of infectious diseases, 174, 1996, pp. 65-72
LIVE SUBGROUP-B RESPIRATORY SYNCYTIAL VIRUS-VACCINES THAT ARE ATTENUATED, GENETICALLY STABLE, AND IMMUNOGENIC IN RODENTS AND NONHUMAN-PRIMATES
Authors: CROWE JE BUI PT FIRESTONE CY CONNORS M ELKINS WR CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., LIVE SUBGROUP-B RESPIRATORY SYNCYTIAL VIRUS-VACCINES THAT ARE ATTENUATED, GENETICALLY STABLE, AND IMMUNOGENIC IN RODENTS AND NONHUMAN-PRIMATES, The Journal of infectious diseases, 173(4), 1996, pp. 829-839
PROGRESS TOWARD THE DEVELOPMENT OF A LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE
Authors: MURPHY BR CROWE JE BUI PT ELKINS WR FIRESTONE CY CHANOCK RM LUBECK MD KARRON R CLEMENTS ML WRIGHT PF SIBER GR
Citation: Br. Murphy et al., PROGRESS TOWARD THE DEVELOPMENT OF A LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE, Journal of cellular biochemistry, 1995, pp. 274-274
COLD PASSAGED, TEMPERATURE-SENSITIVE MUTANTS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) ARE HIGHLY ATTENUATED, IMMUNOGENIC, AND PROTECTIVE IN SERONEGATIVE CHIMPANZEES, EVEN WHEN RSV ANTIBODIES ARE INFUSED SHORTLY BEFORE IMMUNIZATION
Authors: CROWE JE BUI PT SIBER GR ELKINS WR CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., COLD PASSAGED, TEMPERATURE-SENSITIVE MUTANTS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) ARE HIGHLY ATTENUATED, IMMUNOGENIC, AND PROTECTIVE IN SERONEGATIVE CHIMPANZEES, EVEN WHEN RSV ANTIBODIES ARE INFUSED SHORTLY BEFORE IMMUNIZATION, Vaccine, 13(9), 1995, pp. 847-855
ISOLATION AND CHARACTERIZATION OF A HIGHLY ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE CANDIDATE BY MUTAGENESIS OF THE INCOMPLETELY ATTENUATED RSV A2 TS-1 NG-1 MUTANT VIRUS
Authors: HSU KHL CROWE JE LUBECK MD DAVIS AR HUNG PP CHANOCK RM MURPHY BR
Citation: Khl. Hsu et al., ISOLATION AND CHARACTERIZATION OF A HIGHLY ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE CANDIDATE BY MUTAGENESIS OF THE INCOMPLETELY ATTENUATED RSV A2 TS-1 NG-1 MUTANT VIRUS, Vaccine, 13(5), 1995, pp. 509-515
LIVE ATTENUATED MUTANTS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) - IN-VITRO MARKERS AND REPLICATION IN MICE OR CHIMPANZEES CORRELATE WITH LEVELOF ATTENUATION FOR SERONEGATIVE HUMAN INFANTS
Authors: CROWE JE BUI PT KARRON RA CLEMENTS ML WRIGHT PF CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., LIVE ATTENUATED MUTANTS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) - IN-VITRO MARKERS AND REPLICATION IN MICE OR CHIMPANZEES CORRELATE WITH LEVELOF ATTENUATION FOR SERONEGATIVE HUMAN INFANTS, Pediatric research, 37(4), 1995, pp. 172-172
PRODUCTION OF INFECTIOUS HUMAN RESPIRATORY SYNCYTIAL VIRUS FROM CLONED CDNA CONFIRMS AN ESSENTIAL ROLE FOR THE TRANSCRIPTION ELONGATION-FACTOR FROM THE 5'-PROXIMAL OPEN READING FRAME OF THE M2 MESSENGER-RNA INGENE-EXPRESSION AND PROVIDES A CAPABILITY FOR VACCINE DEVELOPMENT
Authors: COLLINS PL HILL MG CAMARGO E GROSFELD H CHANOCK RM MURPHY BR
Citation: Pl. Collins et al., PRODUCTION OF INFECTIOUS HUMAN RESPIRATORY SYNCYTIAL VIRUS FROM CLONED CDNA CONFIRMS AN ESSENTIAL ROLE FOR THE TRANSCRIPTION ELONGATION-FACTOR FROM THE 5'-PROXIMAL OPEN READING FRAME OF THE M2 MESSENGER-RNA INGENE-EXPRESSION AND PROVIDES A CAPABILITY FOR VACCINE DEVELOPMENT, Proceedings of the National Academy of Sciences of the United Statesof America, 92(25), 1995, pp. 11563-11567
ISOLATION AND CHARACTERIZATION OF A CHIMPANZEE MONOCLONAL-ANTIBODY TOTHE G-GLYCOPROTEIN OF HUMAN RESPIRATORY SYNCYTIAL VIRUS
Authors: CROWE JE CHEUNG PYK WALLACE EF CHANOCK RM LARRICK JW MURPHY BR FRY K
Citation: Je. Crowe et al., ISOLATION AND CHARACTERIZATION OF A CHIMPANZEE MONOCLONAL-ANTIBODY TOTHE G-GLYCOPROTEIN OF HUMAN RESPIRATORY SYNCYTIAL VIRUS, Clinical and diagnostic laboratory immunology, 1(6), 1994, pp. 701-706
A FURTHER ATTENUATED DERIVATIVE OF A COLD-PASSAGED TEMPERATURE-SENSITIVE MUTANT OF HUMAN RESPIRATORY SYNCYTIAL VIRUS RETAINS IMMUNOGENICITYAND PROTECTIVE EFFICACY AGAINST WILD-TYPE CHALLENGE IN SERONEGATIVE CHIMPANZEES
Authors: CROWE JE BUI PT DAVIS AR CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., A FURTHER ATTENUATED DERIVATIVE OF A COLD-PASSAGED TEMPERATURE-SENSITIVE MUTANT OF HUMAN RESPIRATORY SYNCYTIAL VIRUS RETAINS IMMUNOGENICITYAND PROTECTIVE EFFICACY AGAINST WILD-TYPE CHALLENGE IN SERONEGATIVE CHIMPANZEES, Vaccine, 12(9), 1994, pp. 783-790
SATISFACTORILY ATTENUATED AND PROTECTIVE MUTANTS DERIVED FROM A PARTIALLY ATTENUATED COLD-PASSAGED RESPIRATORY SYNCYTIAL VIRUS MUTANT BY INTRODUCTION OF ADDITIONAL ATTENUATING MUTATIONS DURING CHEMICAL MUTAGENESIS
Authors: CROWE JE BUI PT LONDON WT DAVIS AR HUNG PP CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., SATISFACTORILY ATTENUATED AND PROTECTIVE MUTANTS DERIVED FROM A PARTIALLY ATTENUATED COLD-PASSAGED RESPIRATORY SYNCYTIAL VIRUS MUTANT BY INTRODUCTION OF ADDITIONAL ATTENUATING MUTATIONS DURING CHEMICAL MUTAGENESIS, Vaccine, 12(8), 1994, pp. 691-699
AN UPDATE ON APPROACHES TO THE DEVELOPMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS TYPE-3 (PIV3) VACCINES
Authors: MURPHY BR HALL SL KULKARNI AB CROWE JE COLLINS PL CONNORS M KARRON RA CHANOCK RM
Citation: Br. Murphy et al., AN UPDATE ON APPROACHES TO THE DEVELOPMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS TYPE-3 (PIV3) VACCINES, Virus research, 32(1), 1994, pp. 13-36
RECOMBINANT HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) MONOCLONAL-ANTIBODY FAB IS EFFECTIVE THERAPEUTICALLY WHEN INTRODUCED DIRECTLY INTO THE LUNGS OF RSV-INFECTED MICE
Authors: CROWE JE MURPHY BR CHANOCK RM WILLIAMSON RA BARBAS CF BURTON DR
Citation: Je. Crowe et al., RECOMBINANT HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) MONOCLONAL-ANTIBODY FAB IS EFFECTIVE THERAPEUTICALLY WHEN INTRODUCED DIRECTLY INTO THE LUNGS OF RSV-INFECTED MICE, Proceedings of the National Academy of Sciences of the United Statesof America, 91(4), 1994, pp. 1386-1390
SELECTION OF COLD-ADAPTED MUTANTS OF HUMAN ROTAVIRUSES THAT EXHIBIT VARIOUS DEGREES OF GROWTH RESTRICTION IN-VITRO
Authors: HOSHINO Y KAPIKIAN AZ CHANOCK RM
Citation: Y. Hoshino et al., SELECTION OF COLD-ADAPTED MUTANTS OF HUMAN ROTAVIRUSES THAT EXHIBIT VARIOUS DEGREES OF GROWTH RESTRICTION IN-VITRO, Journal of virology, 68(11), 1994, pp. 7598-7602
HUMAN MONOCLONAL-ANTIBODY FAB FRAGMENTS CLONED FROM COMBINATORIAL LIBRARIES - POTENTIAL USEFULNESS IN PREVENTION AND OR TREATMENT OF MAJOR HUMAN VIRAL DISEASES/
Authors: CHANOCK RM CROWE JE MURPHY BR BURTON DR
Citation: Rm. Chanock et al., HUMAN MONOCLONAL-ANTIBODY FAB FRAGMENTS CLONED FROM COMBINATORIAL LIBRARIES - POTENTIAL USEFULNESS IN PREVENTION AND OR TREATMENT OF MAJOR HUMAN VIRAL DISEASES/, Infectious agents and disease, 2(3), 1993, pp. 118-131
A COMPARISON IN CHIMPANZEES OF THE IMMUNOGENICITY AND EFFICACY OF LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) TEMPERATURE-SENSITIVE MUTANT VACCINES AND VACCINIA VIRUS RECOMBINANTS THAT EXPRESS THE SURFACE GLYCOPROTEINS OF RSV
Authors: CROWE JE COLLINS PL LONDON WT CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., A COMPARISON IN CHIMPANZEES OF THE IMMUNOGENICITY AND EFFICACY OF LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) TEMPERATURE-SENSITIVE MUTANT VACCINES AND VACCINIA VIRUS RECOMBINANTS THAT EXPRESS THE SURFACE GLYCOPROTEINS OF RSV, Vaccine, 11(14), 1993, pp. 1395-1404
THE REMAINING STOCKS OF SMALLPOX VIRUS SHOULD BE DESTROYED
Authors: MAHY BWJ ALMOND JW BERNS KI CHANOCK RM LVOV DK PETTERSSON RF SCHATZMAYR HG FENNER F
Citation: Bwj. Mahy et al., THE REMAINING STOCKS OF SMALLPOX VIRUS SHOULD BE DESTROYED, Science, 262(5137), 1993, pp. 1223-1224
Risultati: 1-23 |